What is the probability of a sibling and daughter being a viable match for a stem cell transplant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Probability of Siblings and Daughters Being Viable Stem Cell Transplant Donors

For siblings, there is only a 25% chance of finding a full HLA match, while for children (including daughters), the probability is significantly lower due to the inheritance pattern of HLA genes. 1

HLA Matching Requirements for Stem Cell Transplantation

  • Close HLA matching is essential for successful engraftment and minimizing the risk of potentially fatal graft-versus-host disease (GVHD) 1
  • The gold standard for transplantation is a high-resolution match at HLA-A, -B, -C, -DRB1, and -DQB1 loci (10/10 match) 2
  • Sibling donors who are HLA-matched represent the best option for hematopoietic stem cell transplantation (HSCT) 1

Probability of Finding a Matched Sibling Donor

  • There is only a 25% chance of identifying a full HLA match in a sibling donor 1
  • This probability is based on Mendelian inheritance patterns of HLA haplotypes 1
  • The chance of finding a matching sibling varies with family size and is higher in populations with larger families (up to 60% in some populations with larger family sizes) 3
  • Age is also a factor - younger patients (0-5 years) have a lower chance (43%) of finding a matched sibling compared to adults (68%) 3

Probability of Finding a Matched Child Donor

  • The probability of a child (including a daughter) being an HLA match for a parent is significantly lower than the 25% chance with siblings 2
  • This is because a child inherits only one haplotype from each parent, making it impossible for a child to be a full HLA match unless the parent is homozygous for HLA or the other parent coincidentally shares HLA haplotypes 2
  • In practical terms, children are more likely to be haploidentical (half-matched) donors for their parents rather than full matches 4

Alternative Donor Options When Siblings or Children Are Not Matches

  • Only approximately 30% of patients have an HLA-genotypically identical sibling donor available 2
  • For the remaining 70%, alternative sources include:
    • Matched unrelated donors (MUD) from registries 1, 2
    • Haploidentical donors (half-matched family members) 4
    • Umbilical cord blood units 1, 5
  • In most European populations, a 10/10 matched unrelated donor can be found for at least 50% of patients, and an additional 20-30% may have a 9/10 matched donor 2
  • Haploidentical transplantation with post-transplant cyclophosphamide has shown comparable outcomes to matched unrelated donor transplantation 4

Special Considerations

  • Ethnic background significantly affects the probability of finding matched unrelated donors, with non-white patients having a lower chance due to genetic heterogeneity and underrepresentation in donor registries 1
  • Pre-implantation HLA matching (selecting embryos that are HLA-compatible with an existing sick child) is an emerging option for families planning to have another child who could serve as a donor 5
  • Umbilical cord blood allows for successful transplantation even with partial HLA mismatches, providing an alternative when no fully matched donor is available 1

Transplant Outcomes Based on Donor Type

  • One-year survival rates after sibling HLA-matched cord blood stem cell transplantation can be as high as 75-90% 1
  • Disease-free survival for matched sibling donor recipients can reach 72.3% versus 62.4% for alternative donors 6
  • The main difference in outcomes between matched sibling and alternative donors is often related to treatment-related mortality rather than relapse rates 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Chances of finding an HLA-matched sibling: The Saudi experience.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009

Research

Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.